These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22282545)

  • 1. Mesothelioma incidence projections in South East England.
    Riaz SP; Coupland VH; Lüchtenborg M; Peake MD; Møller H
    Eur Respir J; 2012 Oct; 40(4):965-8. PubMed ID: 22282545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tuscany mesothelioma registry (1988-2000): evaluation of asbestos exposure].
    Gorini G; Silvestri S; Merler E; Chellini E; Cacciarini V; Seniori Costantini AS
    Med Lav; 2002; 93(6):507-18. PubMed ID: 12596421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Incidence of malignant mesothelioma (1980-1999) and asbestos exposure in 190 cases diagnosed among residents of the province of Brescia].
    Barbieri PG; Lombardi S; Candela A; Pezzotti C; Binda I
    Med Lav; 2001; 92(4):249-62. PubMed ID: 11676187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The incidence of malignant mesothelioma (1977-1996) and asbestos exposure in the population of an area neighboring Lake Iseo, northern Italy].
    Barbieri PG; Migliori M; Merler E
    Med Lav; 1999; 90(6):762-75. PubMed ID: 10703192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US mesothelioma patterns 1973-2002: indicators of change and insights into background rates.
    Teta MJ; Mink PJ; Lau E; Sceurman BK; Foster ED
    Eur J Cancer Prev; 2008 Nov; 17(6):525-34. PubMed ID: 18941374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignant mesothelioma in Basse-Normandie, a French population study. Descriptive analysis, prognostic factors and survival].
    Desoubeaux N; Bouvier V; Gervais R; Galateau-Salle F; Thibon P; Leplumey T; Herbert C; Lecherbonnier Y; Daviet JP; Letourneux M
    Rev Epidemiol Sante Publique; 2001 Dec; 49(6):523-9. PubMed ID: 11845101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Explaining Alberta's rising mesothelioma rates.
    Cree M; Lalji M; Jiang B; Carriere KC; Beach J; Kamruzzaman A
    Chronic Dis Can; 2009; 29(4):144-52. PubMed ID: 19804678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleural mesothelioma in Sweden: an analysis of the incidence according to the use of asbestos.
    Järvholm B; Englund A; Albin M
    Occup Environ Med; 1999 Feb; 56(2):110-3. PubMed ID: 10448315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence trends of mesothelioma in Norway, 1965-1999.
    Ulvestad B; Kjaerheim K; Møller B; Andersen A
    Int J Cancer; 2003 Oct; 107(1):94-8. PubMed ID: 12925962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estimates of pleural mesothelioma incidence in the Lazio region (Italy), 1997-2000].
    Palange S; Ascoli V; Carnovale-Scalzo C; Forastiere F; D'Ippoliti D; Presti EL; Di Domenicantonio R; Pasetto R; Perucci CA
    Med Lav; 2004; 95(1):45-54. PubMed ID: 15112747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental exposure to asbestos in asbestos cement workers: a case of additional exposure from indiscriminate use of industrial wastes.
    Szeszenia-Dabrowska N; Wilczyńska U; Szymczak W; Laskowicz K
    Int J Occup Med Environ Health; 1998; 11(2):171-7. PubMed ID: 9753896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005.
    Price B; Ware A
    Crit Rev Toxicol; 2009; 39(7):576-88. PubMed ID: 19650718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of malignant mesothelioma of the pleura in Québec and Canada from 1984 to 2007, and projections from 2008 to 2032.
    Krupoves A; Camus M; De Guire L
    Am J Ind Med; 2015 May; 58(5):473-82. PubMed ID: 25754500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peculiar features of mesothelioma occurrence as related to exposure patterns and circumstances in the Lombard Region, Italy.
    Pesatori AC; Mensi C
    Med Lav; 2005; 96(4):354-9. PubMed ID: 16457432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased mesothelioma incidence in New Zealand: the asbestos-cancer epidemic has started.
    Kjellstrom T; Smartt P
    N Z Med J; 2000 Nov; 113(1122):485-90. PubMed ID: 11198540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The experience of the Mesothelioma Registry of Tuscany in assessing health hazard associated with asbestos exposure.
    Seniori Costantini A; Chellini E
    Med Lav; 1997; 88(4):310-5. PubMed ID: 9396216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Future increase of the incidence of mesothelioma due to occupational exposure to asbestos in the past].
    Burdorf A; Barendregt JJ; Swuste PH; Heederik DJ
    Ned Tijdschr Geneeskd; 1997 May; 141(22):1093-8. PubMed ID: 9380136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant mesothelioma in Hong Kong.
    Chang KC; Leung CC; Tam CM; Yu WC; Hui DS; Lam WK
    Respir Med; 2006 Jan; 100(1):75-82. PubMed ID: 15941656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of occupational and environmental asbestos exposure on the incidence of malignant mesothelioma in Connecticut.
    Lewinsohn HC; Meigs JW; Teta MJ; Flannery JT
    IARC Sci Publ; 1980; (30):655-60. PubMed ID: 7228320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latency periods in asbestos-related mesothelioma of the pleura.
    Bianchi C; Giarelli L; Grandi G; Brollo A; Ramani L; Zuch C
    Eur J Cancer Prev; 1997 Apr; 6(2):162-6. PubMed ID: 9237066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.